Laboratory Diagnosis of Spontaneous Bacterial Peritonitis
NCT ID: NCT05696054
Last Updated: 2023-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2023-02-15
2023-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic of Spontaneous Bacterial Peritonitis
NCT01193426
Early Ascitis Parencentesis in SBP
NCT06679842
Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure
NCT01852630
Evaluation of Serum Procalcitonin in Critically Ill Patients With Suspected Sepsis
NCT03506152
Procalcitonin in Cirrhotic Patients at High Risk for Sepsis
NCT01578226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SBP group
Patients diagnosed as spontaneous bacterial peritonitis based on ascitic fluid study.
No interventions assigned to this group
non-SBP group
Patients without spontaneous bacterial peritonitis based on ascitic fluid study
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* malignancy.
* Antibiotic therapy before hospital admission.
* Chemotherapy or radiotherapy within 1 month before admission.
* Pancreatic diseases.
* contraindication to paracentesis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amira Maher
Lecturer of Tropical Medicine and Gastroenterology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
246810
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.